Background: Few studies have investigated congenital anomalies in relation to municipal waste incinerators (MWIs) and results are inconclusive. Objectives: To conduct a national investigation into the risk of congenital anomalies in babies born to mothers living within 10 km of an MWI associated with: i) modelled concentrations of PM 10 as a proxy for MWI emissions more generally and; ii) proximity of residential postcode to nearest MWI, in areas in England and Scotland that are covered by a congenital anomaly register. Methods: Retrospective population-based cohort study within 10 km of 10 MWIs in England and Scotland operating between 2003 and 2010. Exposure was proximity to MWI and log of daily mean modelled ground-level particulate matter ≤10 μm diameter (PM 10 ) concentrations. Results: Analysis included 219,486 births, stillbirths and terminations of pregnancy for fetal anomaly of which 5154 were cases of congenital anomalies. Fully adjusted odds ratio (OR) per doubling in PM 10 was: 1·00 (95% CI 0·98-1·02) for all congenital anomalies; 0·99 (0·97-1·01) for all congenital anomalies excluding chromosomal anomalies. For every 1 km closer to an MWI adjusted OR was: 1·02 (1·00-1·04) for all congenital anomalies https://doi.
Introduction
Over the last 20 years, the move to reduce landfill waste has driven an increase in waste incineration in the European Union (EU) (Ashworth et al., 2014) . Municipal waste incinerators (MWIs) burn nonhazardous waste mostly from households and commercial establishments, at high temperatures. Emissions from MWIs are currently regulated under the EU Industrial Emissions Directive (IED) (2010/75/ EU) (Candela et al., 2013) , which incorporated the Waste Incineration Directive (EU-WID) (2000/76/EC) implemented in Great Britain (GB) on 28 December 2002 and 28 December 2005 for new and existing MWIs respectively. Emissions include particulates, sulphur dioxide (SO 2 ), nitrogen oxides (NO X ), heavy metals, polychlorinated dibenzo-pdioxins and furans (PCDD/Fs), polycyclic aromatic hydrocarbon (PAH) and polychlorinated biphenyls (PCBs). Limits for MWI emissions are set by the EU under the IED. However, there remains public concern and scientific uncertainty about possible health effects on the population exposed to emissions from MWIs (Candela et al., 2015) .
In a recent systematic review (subsequently updated for this research) of the association between municipal waste incineration and birth outcomes, results were inconsistent and inconclusive (Ciuta et al., 2012; Cordier et al., 2004; Cordier et al., 2010; Cordioli et al., 2013) . There are few investigations of municipal waste incineration and health specifically focussed on congenital anomalies (COT, 2010; Cresswell et al., 2003; Dolk and Vrijheid, 2003; Dolk et al., 2004; Douglas et al., 2017; Dummer et al., 2003; Elliott et al., 2009; European Union, 2010; Garne et al., 2011; Ghosh et al., 2018) . The start dates of all these studies pre-date the implementation of the Industrial Emissions Directive for existing MWIs (28 December 2005) . Five separate studies have found some increased risks with specific congenital anomaly groups, and include facial clefts (Douglas et al., 2017; European Union, 2010) , renal and urological anomalies (Dolk et al., 2004; Douglas et al., 2017) neural tube defects, spina bifida and lethal congenital heart defects (CHDs) (Elliott et al., 2009) and deaths due to all congenital anomalies combined (Ghosh et al., 2018) . These inconsistent findings may reflect chance findings related to small numbers of cases in some studies, different types of MWIs with differing exposure profiles, varying study designs and limitations in exposure assessment.
The study aim was to conduct a national investigation into the risk of congenital anomalies in babies born to mothers living within 10 km of an MWI associated with: i) modelled concentrations of PM 10 as a proxy for MWI emissions more generally and; ii) proximity of residential postcode to nearest MWI, in areas in England and Scotland that are covered by a congenital anomaly register.
Methods

Study area
The study area was defined as all centroids of postcodes (representing on average 12 households) occurring within a 10 km radius of at least one MWI in a region of England or Scotland covered by a participating Regional Congenital Anomaly Register (RCAR) during the study period 1 April 2003 to 31 December 2010 (the RCAR for Wales did not take part in this study). Fig. 1 shows the 11 MWIs and RCARs eligible for inclusion in the study, covering approximately 24·5 million of the population of England and Scotland. Grundon MWI commenced operation in February 2010 so there were too few congenital anomalies during the study period to be included.
Outcomes
The primary outcome groups analysed were:
• One or more congenital anomalies (International Classification of Diseases tenth revision (ICD 10 ) codes: Q00 -Q99, D215, D821, D1810, P350, P351, P371)
• Specific congenital anomaly groups based on previous evidence (nervous System (Q00-Q07 excl. Q0461, Q0782), congenital heart defects (CHDs) (Q20-Q26 excluding Q2111, Q2541, Q261, Q250 (< 37 weeks gestation), Q256 (< 37 weeks gestation)), abdominal wall defects (Q792, Q793, Q795, Q7950, Q7951, Q7959), orofacial clefts (Q35-Q37), limb defects (Q65-Q74 excluding Q653-Q656, Q662-Q678, Q680-685, Q7400), digestive system (Q790, Q38-Q45 excluding Q381, Q382, Q3850, Q400, Q401, Q4021, Q430, Q4320, Q4381, Q4382), urinary (Q60-Q64, Q794 excluding Q610, Q627, Q633), genital organs (Q50-Q52, Q54-Q56 excluding Q523, Q525, Q527, Q5520, Q5521)) Secondary outcome groups analysed were:
• One or more congenital anomalies excluding chromosomal congenital anomalies (Q90-Q99).
• Specific congenital anomaly sub-groups (neural tube defects (Q00, Q01, Q05), severe CHDs (Q200-Q204, Q212, Q213, Q220, Q224 -Q226, Q230, Q232-Q234, Q251, Q252, Q262), gastroschisis (Q793), cleft palate (Q35), cleft lip with or without cleft palate (Q36, Q37), limb reduction defects (Q71-Q73), oesophageal atresia (Q390, Q391, Q3911), anomalies of the renal system (Q60-Q61 excluding Q610), obstructive defects of renal pelvis (Q62, Q64 excluding Q627), hypospadias (Q54)).
Descriptions of ICD 10 codes are listed in Table S1 For data governance reasons, we were unable to link records in the English RCARs with other datasets; consequently all live-born babies affected by a congenital anomaly in England (estimated to be 2·3% by the British Isles Network of Congenital Anomaly Registers (BINOCAR)) are duplicated in the denominator dataset. Data from Scotland were provided in a single dataset, avoiding duplicates. Fig. 2 summarises the datasets involved and how they were combined.
The English RCAR data are supplied to the European surveillance of congenital anomalies (EUROCAT) which requires the exclusion of minor anomalies. In Scotland the data are not supplied to EUROCAT and, due to a technical issue, the Scottish congenital anomaly data supplied to us did not include the 5th character of the ICD 10 code, meaning it was not possible to be certain if all cases can be correctly identified as minor or major. No data on TOPFAs are available for Scotland resulting in a potential underestimation of congenital anomaly rates in Scotland.
Harmonising the English and Scottish data involved:
• Removing cases of congenital anomalies from the Scottish data that could be identified as minor based on the EUROCAT codes.
• Identifying inconsistencies of rates of certain anomalies between the English and Scottish data, e.g. excluding 70 cases of ICD 10 Q828 (other specified congenital malformations of skin) in Scotland as these were likely to be minor. Higher rates for certain ICDs in England compared to Scotland could be explained by the absence of TOPFA and prenatal data for Scotland.
Cases with multiple congenital anomalies were counted once for each case when analysing all congenital anomalies combined and all congenital anomalies excluding chromosomal, and under each outcome when analysing specific congenital anomalies groups and sub-groups. So an individual with multiple congenital anomalies may appear more than once when analysing separate congenital anomalies groups and sub-groups. When excluding chromosomal anomalies, it was assumed that the presence of a chromosomal anomaly was the underlying cause of any additional (non-chromosomal) anomalies (Health Protection Agency, 2009).
All birth records (births, stillbirths and TOPFAs) in the study area were included if conception was after 1 April 2003 and birth or Parkes, et al. Environment International xxx (xxxx) xxxx termination was before 31 December 2010 and the mother's residence at birth or termination was within 10 km of an operational MWI.
Exposure assessment
We used two metrics to represent 'exposure' to MWI emissions: i) dispersion modelling using ADMS-Urban software from Cambridge Environmental Research Consultants (CERC), taking account of meteorological factors including wind direction -to estimate daily mean ground-level PM 10 concentrations from MWI emissions at each postcode centroid within 10 km of the included MWIs (as a proxy for MWI emissions more generally), as previously described by Douglas et al. (Hodgson et al., 2015) and references therein; ii) proximity to nearest MWI -calculated as a continuous measure of straight line distance of the MWI coordinates to the postcode centroid of mother's residence at time of birth.
Most congenital anomalies are known to occur in the first trimester of pregnancy (Jansson and Voog, 1988 ); hence we defined the critical window of exposure for the dispersion modelling as the 91 days prior to calculated/estimated date of conception (to cover the sperm regeneration cycle) plus the first trimester of pregnancy (with exposure represented by mean PM 10 concentration over the period). Two separate sensitivity analyses were run using just the 91 days prior to calculated/estimated date of conception and just the first trimester as exposure periods (see supplemental table S5 for details of sensitivity analyses). For births after the start of 2006, the gestational age at birth was available allowing us to estimate the conception date by subtracting the gestational age from the date of birth. For births prior to 2006, the pregnancy was assumed to be 279 days which was the median pregnancy duration for the births in our dataset 2006-2010. Exposure could not be estimated for all individuals as not all MWIs in the study were operational by the start of 2003; some MWIs had periods of nonoperation and data from SWCAR were only available from the start of 2005 (see Douglas et al. (Hodgson et al., 2015) for details of MWI operating dates). As the distribution of the modelled PM 10 concentrations was heavily right-skewed, PM 10 concentrations were log transformed prior to analysis. We used mother's residential postcode at birth for the distance-based analyses.
Potential confounders
Potential confounders were selected a priori to reflect factors that have previously been associated with risk of congenital anomalies (see supplemental table S2). Individual level confounders were maternal age (categories in years: < 20; 20-29; 30-39; > 40) and year of birth or termination. Area-level confounders were deprivation by fifths of the Carstairs deprivation index (comprising lack of car ownership, low occupational social class, overcrowded households and male unemployment at the census output area (COA) level -comprising 40-250 households) and area-level ethnicity (% of white women aged 16-49 at the middle layer super output area (MSOA) level -2000-6000 households). In addition, major road density (length of motorways, A-roads and B-roads) within 10 km of the MWI, major road density within 250 m of mother's postcode and other sources of emissions were used as proxies for background air pollution. The data for 'other sources of emissions' were based on the total number of industries in operation within 10 km of each MWI for each year of operation, obtained from the Environment Agency in England and the Scottish Pollutant Release Inventory (Table S3 ).
Sensitivity analyses additionally adjusted for: sex; individual level ethnicity (only available for England after 2006); tobacco sales (not available in Scotland) at COA level, as a proxy for smoking; and multiple births (see Supplemental Material, Table S5 for details of sensitivity analyses).
Statistical analysis
We used logistic regression to examine associations between each measure of exposure and outcome, adjusting for available potential confounders listed above. We did not have information on MWI feedstocks; these were likely to be heterogeneous with relative pollutant concentrations emitted varying between MWIs; we therefore included a random slope for the PM 10 exposure variable in all models. We also included a random intercept for MWI to allow for possible unmeasured confounding effects e.g. other local sources of pollution for which only area level proxies were available. As PM 10 data were log transformed, odds ratios (ORs) indicate the risk associated with a multiplicative increase in PM 10 concentrations; here we report the risk associated with a doubling (100% increase) in MWI emission-related PM 10 , i.e. an OR of 1·1 would indicate a 10% increase in risk each time the PM 10 concentration is doubled. Our primary analysis was fully adjusted logistic regression with a random intercept for MWI and random slope for the PM 10 exposure variable.
To evaluate associations of MWI emissions and proximity, we present odds ratios and 95% confidence intervals. In view of the large number of analyses, we also present p-values adjusted for multiple testing using the procedure proposed by Simes which is recommended when several tests may be highly correlated (Ormond et al., 2009 ). All analyses were conducted in R version 3.2.2 (available from: https:// www.R-project.org) (R Core Team, 2015) . See Supplemental Material for details of regression models.
Results
After exclusions (Fig. 2) we included 219,486 births, stillbirths and terminations of pregnancy for fetal anomaly of which 5154 were cases of congenital anomalies (Table 1) . Mean modelled PM 10 concentrations for 91 day pre-pregnancy period and first trimester was 0·64 10 −3 μg/m (Candela et al., 2015) [IQR 0·14-0·76] and 0·67 10 −3 μg/m (Candela et al., 2015) [IQR 0·14-0·80] for the births and congenital anomaly cases respectively (Table 2) . Mean distance from postcode of maternal residence to nearest MWI was 5·44 km [IQR 3·57-7·23] and 5·28 km [IQR 3·45-7·03] for births and cases respectively. No births were within 10 km of more than one MWI (Fig. 1 ). Numbers of congenital anomaly cases by ICD group and sub-group are listed in table S10.
There was limited correlation between proximity to nearest MWI and modelled PM 10 , percent of non-white women and deprivation (Pearson correlation = 0·31 (95% CI 0·30-0·31) for PM 10 , 0·45 (0·45-0·46) ethnicity and 0·22 (0·22-0·22) deprivation) (table S4) .
We found no associations between modelled PM 10 concentrations from MWIs and all congenital anomalies when fully adjusted for confounders (Table 3a , Table S11a ). However, with proximity to nearest MWI, there was a small (2%) excess risk of all congenital anomalies combined for each kilometre closer to the MWI [OR 1·02; 95% CI 1·00-1·04] ( Table 3b , Table S11b ).
There were no significant associations between modelled PM 10 and any of the individual congenital anomalies groups and sub-groups after fully adjusting for confounders (Table 4a ). Associations with proximity to nearest MWI were found for CHDs [OR 1·04; 95% CI 1·01-1·08] and genital anomalies [OR 1·07; 95% CI 1·02-1·12] (Table 4b) which make up the majority of the excess risk found when analysing all congenital anomalies. For hypospadias, which make up 85·6% of genital anomalies, there was a 7% excess risk for each kilometre closer to the MWI [OR 1·07; 95% CI 1·01-1·12].
After Simes procedure adjustment for multiple testing, p-values were robust to adjustment for genital anomalies but not for CHDs (table  S12) . Findings from sensitivity analyses showed no material difference to those from main models (table S6) , other than addition of individual ethnicity as a confounder; this is likely due to bias introduced by the difference in completeness of individual ethnicity data between numerator (38·3%) and denominator (73·8%) datasets. Additionally, the analysis that excluded area-level covariates (deprivation and ethnicity) showed a slightly larger association between all congenital anomalies and proximity to nearest MWI [OR 1·03; 95% CI 1·01-1·04]. The majority of exclusions (3.3%) were due to incomplete exposure data (Fig. 2) , because birth events were excluded if > 10% of ADMS data was missing for the exposure period. To investigate the effect of this we ran 2 sensitivity analyses with exclusion criteria of 5% and 15% as the cut-off points for missing ADMS data. The results were similar to those using the default 10% cut-off point for missing ADMS data (see supplemental table S6).
Discussion
With inclusion of 219,486 births, including 5154 cases, this study is one of the largest to examine the risk of congenital anomalies near MWIs. Both modelled concentrations of PM 10 from MWI emissions and incinerator proximity were used as indicators of potential exposure to pollution from MWIs. We found no increased risk of congenital anomalies associated with modelled concentrations of PM 10 but small increases in risk across all congenital anomalies, CHDs and genital anomalies with proximity to the nearest MWI. The limited correlation between proximity to nearest MWI and modelled PM 10 (Pearson correlation = 0·31) suggests that they are estimating different entities and may at least partly explain the differing results for the two metrics.
Comparison with related studies
In line with our study findings, no previous studies have found associations of MWI emissions with all congenital anomalies combined or all congenital anomalies excluding chromosomal anomalies. Dummer et al. (Elliott et al., 2009) in their study examining congenital anomalies in relation to four incinerators in a county of England in 1956-1993, found an association between proximity and lethal CHDs [OR: 1·12; 95% CI 1·03-1·22, continuous odds ratio using the distance function 1/ (D + 0·1) (Candela et al., 2013) where D is the distance in km from the incinerator]. Similarly, in our study, we found a 4% excess risk of CHDs (95% CI 1·01-1·08) for every 1 km closer to an MWI when considering proximity to nearest MWI; however, there was no association between Table S3 ).
severe CHDs and proximity to nearest MWI [OR: 1·02; 95% CI 0·97-1·07] (Table 4b ). While a previous study found a link between CHDs and landfill sites (Rankin et al., 2009 ) causality has been debated (Rose et al., 2009) . All four previous studies investigating the risk of congenital anomalies by modelling exposure from MWI emissions (COT, 2010; Cresswell et al., 2003; Dolk and Vrijheid, 2003; Dolk et al., 2004; Douglas et al., 2017) used modelled maternal exposure to dioxins. Of these, only the studies by Cordier et al. (Dolk et al., 2004; Douglas et al., 2017) found evidence of increased risk of some congenital anomalies subgroups (facial clefts, renal dysplasia and urinary tract defects). We did not find excess of these specific anomalies and modelled PM 10 concentrations in our study, although we did not model maternal exposure to dioxins.
No published study on MWIs to date has found associations with genital anomalies and/or hypospadias. The aetiology of hypospadias is largely unknown (Santoro et al., 2016) ; it has been suspected that maternal exposure to endocrine disrupting chemicals is a risk factor, but evidence is inconsistent (Simes, 1986) . Elevated risks of hypospadias have been reported near landfill sites but may reflect residual confounding (Rankin et al., 2009 ).
Strength and limitations
In this large retrospective cohort study we included all available live birth, stillbirth, termination and congenital anomaly registration data in the study area and period thus minimising selection bias (< 3.5% exclusions). We used modelled PM 10 concentrations as a means to investigate effects of MWI emissions, as well as proximity to a MWI. These were based on postcode centroid of the mother's residence although not the exact address, and do not account for migration during pregnancy or paternal residence and exposure prior to the exposure period, all of which may have led to misclassification bias (Tango et al., 2004) . The PM 10 concentrations were modelled using a Gaussian dispersion model treated deterministically rather than probabilistically, potentially narrowing the confidence intervals for the analysis results. Our models adjusted for other sources of pollution based on permits to pollute in the vicinity of the MWI, and for road density which has been shown to be a useful proxy for road traffic air pollution (ten Tusscher et al., 2000) , but these will not capture exposure to all local sources of pollutants. We were reliant on modelling since we did not have individual-level measurements of exposures to MWI emissions for the hundreds of thousands of mothers included in the study, nor would it be feasible to collect such data. Use of a dispersion model assuming primary airborne exposure (as in our study) has been recommended to reduce exposure misclassification (Varela et al., 2009) . We found statistically significant correlations between in-stack measurements of PM 10 and some heavy metals, polycyclic aromatic hydrocarbons and polychlorinated biphenyls (Hodgson et al., 2015; Vehlow et al., 2007) , all of which have previously been associated with risks of congenital anomalies (Vinceti et al., 2008) . However, based on limited measurement data, we found weaker correlations between in-stack measurements of PM 10 and compounds of mercury or polychlorinated dibenzop-dioxins and furans (PCDD/Fs) (Spearman's correlation values of r = 0·11-0·15) (Hodgson et al., 2015; Vehlow et al., 2007) , which have been associated with increased risks of congenital anomalies (Santoro et al., 2016; Vinceti et al., 2008) , specifically with modelled waste incinerator dioxin emissions (Dolk et al., 2004) .
Distance is a cruder measure but may pick up other potentially toxic emissions accumulating through non-airborne exposure pathways or from local (non-stack) emissions. These might include, for example, emissions from waste handling including waste transportation to the MWI (estimated at 2% to 10% of MWI emissions in a hypothesised case study by Ciuta et al. (Vinceti et al., 2009) ), which may not be picked up by the stack emissions modelling.
We found a weak correlation between proximity to nearest MWI and both deprivation and ethnicity (table S4) and between all congenital anomalies combined and proximity to nearest MWI; while we adjusted at area level for deprivation and ethnicity, previously linked with increased risks of CHD and hypospadias respectively (Santoro et al., 2016; Vinceti et al., 2018) , we did not have the relevant data to adjust for these potential confounders at individual level, and it is possible that association of proximity with these outcomes reflects residual confounding rather than 'true' (causal) effects.
Further considerations include the potential for bias in outcome ascertainment and ambiguity of ICD 10 coding, inconsistent reporting of the severity of certain anomalies across registries and differences between English and Scottish datasets (e.g. lack of TOPFA data in the Scottish data). Of particular relevance is the surveillance of hypospadias cases which is known to be inconsistent with differences in ascertainment between registries (van der Zanden et al., 2012) . In 2004, Dolk et al. (van der Zanden et al., 2012) suggested that the reporting systems in place were unlikely to provide effective surveillance of hypospadias and notably these systems had not changed during our study period.
Conclusions
This study found no increased risk of congenital anomalies in relation to mean modelled PM 10 concentrations from MWIs in England and Scotland as a proxy for MWI emissions more generally. Small increased risks (2-7%) with proximity to the nearest MWI were observed for all congenital anomalies combined, congenital heart defects and genital anomalies, specifically hypospadias. These findings in proximity to MWI might reflect residual confounding, although it is not possible from these data to exclude a potential causal effect even in the absence of associations with modelled PM 10 emissions; further monitoring of exposures and health outcomes near MWIs appears warranted.
Data
Births and deaths data were from the Office for National Statistics (ONS) National Mortality, Births and Stillbirth register for England and Wales and the National Health Service (NHS) Numbers for Babies (NN4B). Scottish births and deaths were from the Information Services Division (ISD) Scotland. TOPFAs were from the Department of Health (now called Department of Health and Social Care).
English data on congenital anomalies are from the British and Irish Network of Congenital Anomaly Researchers (BINOCAR) as well as individual regional congenital anomaly registers (RCARs): Congenital Anomaly Register for Oxfordshire, Berkshire and Buckinghamshire (CAROBB); East Midlands & South Yorkshire Congenital Anomaly Register (EMSYCAR); Northern Congenital Abnormality Survey (NorCAS); South West Congenital Anomaly Register (SWCAR); Wessex Antenatally Detected Anomalies Register (WANDA).
Incinerator emissions data came from the Environment Agency (EA), and Scottish Environment Protection Agency (SEPA).
Data on industrial sites came from the Environment Agency Environmental Permitting Regulations -Industrial sites (England), and the Scottish Pollutant Release Inventory. CACI tobacco expenditure data is © Copyright 1996-2014 CACI Limited. We attest that we have obtained appropriate permissions and paid any required fees for use of copyright protected materials.
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